GenoMar Genetics Group, the world’s leading tilapia breeding company, announced a few days ago the appointment of Rodrigo Zanolo as its new commercial director. Based in Brazil, he will assume responsibility for the group’s commercial activities in Latin America and Asia, including sales, marketing, customer and technical services, the company said. Zanolo will start in his new role on November 7 from the company’s offices in Londrina, in the Brazilian state of Paraná.
“We are delighted to welcome Rodrigo to our team. He is a well-known and committed professional within the tilapia community, and his 16 years of experience in the industry means he has an excellent understanding and knowledge of our customers and the markets in which we operate,” said about the new appointment Alejandro Tola, CEO of GenoMar Genetics Group.
On his part, Zanolo said: “I am very pleased to join GenoMar and look forward to working with the commercial teams in Brazil and around the world to bring an exciting portfolio of brands and products to more customers and segments in the market.”
Strong marketing track record
GenoMar Genetics’ new commercial director is a veterinarian and comes directly from MSD Animal Health, where he has served in various commercial and technical leadership roles, with a strong track record of commercializing technology products in the tilapia value chain.
As a veterinarian (DVM), he holds a Master’s degree in Animal Science and two Masters of Business and Management (MBA) degrees in Marketing and Leadership, respectively.
“I believe that GenoMar’s scientific knowledge, ongoing product development and long-term commitment to the industry will continue to make important contributions to the sustainability and economic performance of Brazilian and global agriculture, as it has for the past 30 years. Genetic improvement is that critical tool that will take our industry to a new level of performance today and in the future,” commented Zanolo after his appointment.
Passion for aquaculture
According to Tola: “Zanolo shares with the rest of us a passion for this industry and a desire to make a positive impact. This appointment once again demonstrates our commitment to grow our position as the leading provider of genetic solutions for the global tilapia industry.”
Recall that GenoMar Genetics Group is an international aquaculture breeding and distribution company focused on global tilapia markets. From its breeding centers in Norway, Asia and Latin America, the company manages innovation and technology programs for some of the industry’s most recognized independent brands such as GenoMar, Aquabel and AquaAmerica.
Their “well-developed and expanding” production infrastructure, as they claim, allows them to rapidly disseminate genetic progress and supply high quality stock year-round to farmers around the world, contributing to a sustainable and profitable tilapia aquaculture industry.
A year of work in Vietnam
A few weeks before the news broke, it was one year since GenoMar Genetics Group delivered its first batch of fingerlings to the Vietnamese market. As they explained in a press release, “the response has been very positive, as more and more fish farmers are harvesting and sharing their data with us”.
The fish farmers, the company explained, “are recognizing the growth, survival capacity and morphology of our fish as differentiating elements, and the profit margins are between 30% and 40%. We look forward to continuing to support the industry with healthy, high-performing genetics.”
In the same days, the company’s team in Vietnam, led by Trung Nguyen Van and Cam Le, hosted its main distributor in the north of the Asian country for a visit to its facilities in Tay Ninh province.